Brimonidine Tartrate And Timolol Maleate Solution/ Drops
Product Images NDC 0832-1425

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate And Timolol Maleate (NDC 0832-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brimonidine 01)

Chemical structure diagram depicting the molecular composition of Brimonidine Tartrate and Timolol Maleate, showing molecular rings and functional groups corresponding to the active ingredients.*

FDA Label Image

Chemical Structure (Brimonidine 02)

Chemical structure diagram showing the molecular structure of brimonidine tartrate, the active ingredient in Brimonidine Tartrate and Timolol Maleate ophthalmic solution. The structure includes rings and functional groups consistent with brimonidine tartrate.*

FDA Label Image

Principal Display Panel (5 mL Bottle Carton)

The packaging label for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution 0.2%/0.5% sterile drops, 5 mL, manufactured for Upsher-Smith Laboratories, LLC. The label includes active ingredient concentrations, storage instructions, and formulation details. It bears the NDC 0832-1425-05 and indicates Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.